Scholarlink

Background <p>Findings on the relation between dementia and cancer have been inconsistent and influenced by methodological biases. Hypothesising that studying preclinical brain dysfunction may better unmask this link, we investigated the association of cancer with motoric cognitive risk syndrome (MCRS), an established dementia prodrome combining slow gait with subjective cognitive complaints.</p> Methods <p>We included 2590 participants from the Rotterdam Study (2009–2015), free of dementia and prevalent cancer at baseline, with gait and cognitive assessment data to define MCRS and mild cognitive impairment (MCI). Cox proportional Hazard models examined the relation of MCRS, MCI, global gait, and individual gait domains with risk of cancer, adjusting for covariates.</p> Results <p>Individuals with MCRS tended to have an increased risk of cancer (HR: 1.26, 95% CI: 0.88–1.80), primarily driven by slow gait. Similarly, individuals with MCI tended to have an increased risk of cancer (HR: 1.29, 95% CI: 0.82–2.04), primarily driven by objective cognitive impairment. Worse global gait conveyed a slightly increased risk of cancer (standardised HR: 1.10, 95% CI: 0.99–1.22), driven by Rhythm, Phases and Variability, with a stronger effect when follow-up was truncated at 3&#xa0;years (standardised HR: 1.22, 95% CI: 1.03–1.45).</p> Conclusions <p>Both individuals with MCRS and individuals with MCI tended to have an increased risk of cancer, supporting the notion of shared mechanisms between neurodegeneration and cancer. The association with gait impairment was most pronounced in the years preceding diagnosis, suggesting subclinical disease may partly underlie this link. These findings highlight motor-cognitive prodromes as informative phenotypes for studying shared vulnerability across neurodegenerative and oncological diseases.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Linking dementia prodromes and cancer through motor function impairment: the Rotterdam-Study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月25日

查看全文
  • Amber P. Selie,
  • A. Charlotte Menart,
  • Kimberly D. van der Willik,
  • Sanne B. Schagen,
  • M. Arfan Ikram

摘要

Background

Findings on the relation between dementia and cancer have been inconsistent and influenced by methodological biases. Hypothesising that studying preclinical brain dysfunction may better unmask this link, we investigated the association of cancer with motoric cognitive risk syndrome (MCRS), an established dementia prodrome combining slow gait with subjective cognitive complaints.

Methods

We included 2590 participants from the Rotterdam Study (2009–2015), free of dementia and prevalent cancer at baseline, with gait and cognitive assessment data to define MCRS and mild cognitive impairment (MCI). Cox proportional Hazard models examined the relation of MCRS, MCI, global gait, and individual gait domains with risk of cancer, adjusting for covariates.

Results

Individuals with MCRS tended to have an increased risk of cancer (HR: 1.26, 95% CI: 0.88–1.80), primarily driven by slow gait. Similarly, individuals with MCI tended to have an increased risk of cancer (HR: 1.29, 95% CI: 0.82–2.04), primarily driven by objective cognitive impairment. Worse global gait conveyed a slightly increased risk of cancer (standardised HR: 1.10, 95% CI: 0.99–1.22), driven by Rhythm, Phases and Variability, with a stronger effect when follow-up was truncated at 3 years (standardised HR: 1.22, 95% CI: 1.03–1.45).

Conclusions

Both individuals with MCRS and individuals with MCI tended to have an increased risk of cancer, supporting the notion of shared mechanisms between neurodegeneration and cancer. The association with gait impairment was most pronounced in the years preceding diagnosis, suggesting subclinical disease may partly underlie this link. These findings highlight motor-cognitive prodromes as informative phenotypes for studying shared vulnerability across neurodegenerative and oncological diseases.